US Patent 12006364 Anti-CD100 antibodies and methods for using the same
Patent 12006364 was granted and assigned to Vaccinex, Inc on June, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 13 Jun, 2024
Golden AI
Edits made to:
Infobox (+12 properties)
Article (+261 characters)
US Patent 12006364 Anti-CD100 antibodies and methods for using the same
Article
Patent abstract
Compositions and methods are provided for treating diseases associated with CD100, including certain autoimmune diseases, inflammatory diseases, and cancers. In particular, anti-CD100 monoclonal antibodies have been developed to neutralize CD100.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Ernest S. Smith0
Terrence Lee Fisher0
Date of Patent
June 11, 2024
0Patent Application Number
175884270
Date Filed
January 31, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12006364 Anti-CD100 antibodies and methods for using the same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
